Aignostics has announced the results of a new pathology foundation model developed with Mayo Clinic, establishing a new standard for performance using a vast dataset of slide images. This model will be incorporated into Aignostics' AI-powered pathology products, enabling organizations in healthcare to utilize it for research and clinical development.
Company Information
Company
Aignostics
Location
Berlin, Berlin, Germany
About
Aignostics is an artificial intelligence (AI) company that transforms complex multimodal pathology data into valuable insights. By leveraging proprietary multimodal clinical data and rigorous scientific methods, Aignostics develops innovative products and services for precision medicine. The company collaborates with biopharmaceutical partners to support drug discovery and development. Established in 2018 as a spin-off from Charité Berlin, Aignostics has garnered significant investment and operates in Berlin and New York.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aignostics ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.